Title
Category
Credits
Event date
Cost
EM2411F "From Mystery to Mastery: Game-Changing Tools for Low-Risk MDS" (IM GR -111524)
  • 1.00 AMA
$0.00
Purpose and OverviewMyelodysplastic syndromes are clonal stem-cell disorders that lead to ineffective hematopoiesis and carry the risk of progression to acute myeloid leukemia. Anemia is the most common cytopenia in patients with lower-risk myelodysplastic syndromes. The progression of this anemia leads to transfusion dependence and detriment to the patient's quality of life due to clinical symptoms and the multiple health-care interactions required to maintain a suitable concentration of hemoglobin.
SRC's International Pediatric Musculoskeletal Ultrasound Symposium 2024 (JS2410B)
  • Pediatrics
  • 11.50 AMA
  • 11.50 Attendance
10/25/2024
$0.00
Brain Summit 2024 Symposium: Current Trends in Neurology (RP2411B)
  • Neurology and Neurological Surgery
  • 6.25 AMA
  • 6.25 Attendance
  • 1.00 Ethics
11/16/2024
$150.00
ABOUT THE SYMPOSIUMThe Brain Summit 2024 Symposium: Current Trends in Neurology is a one-day live CME activity designed for neuroscience professionals - including physicians, advanced practice providers, nurses, and physical therapists - to explore latest advances an
Ophthalmology at the Crossroads 2024 (RP2412D)
  • 5.00 AMA
  • 5.00 Attendance
  • 1.00 Ethics
12/07/2024
$0.00
This one-day live CME activity is designed to bring cutting edge basic and clinical research finding to both the practicing general ophthalmologist and sub-specialist in all fields of ophthalmology. Didactic lectures with interactive discussion address the seven sub-specialty areas of ophthalmology: cornea and external disease, retina and vitreous surgery, pediatric ophthalmology, neuro-ophthalmology, ophthalmic plastic surgery, ophthalmic pathology, and glaucoma. This course also offers a medical ethics lecture
2024 Oncology Year in Review (RP2407A)
  • Oncology
  • 5.00 AMA
  • 5.00 Attendance
12/07/2024
$100.00
This program will provide participants with the latest information available as presented at the 2024 American Society of Clinical Oncology (ASCO) meeting, 2024 European Society for Medical Oncology (ESMO) meeting, and major findings from other meetings that took place in 2024.
47th Annual Carrell Krusen Neuromuscular Symposium (RP2502C)
  • Neurology and Neurological Surgery
  • Pediatrics
  • 9.75 AMA
  • 9.75 Attendance
02/20/2025
$275.00
Bass Symposium 2025: "Emerging Technologies and Practices in Spine Surgery" (RP2503B)
  • 5.25 AMA
  • 5.25 Attendance
03/01/2025
$50.00

Pages